Hutchinson Lands as CEO for Start-up Prematics


By Neil Versel

Feb. 12, 2008 | Less than two weeks after stepping down as chief executive of SureScripts, Kevin Hutchinson has landed as president and CEO of ePrescribing start-up Prematics (Bethesda, Md.), where he will attempt to jump-start physician adoption of the technology.

With Hutchinson still at the helm, SureScripts forecast ePrescribing volume to triple in 2008, but even that would account for just 7 percent of eligible scripts in the U.S. (See “Hutchinson to Step Down as SureScripts Top Exec.”) Hutchinson left SureScripts at the end of January, though he retains his seats on the American Health Information Community and the board of the eHealth Initiative.

“We just haven’t seen a model that worked well in automating the physician side,” Hutchinson tells Digital HealthCare & Productivity. He says this is true not only for himself but for Prematics chairman James Bradley, the founding CEO of another e-prescribing connectivity company, RxHub.

SureScripts is an eRx connectivity network with pharmacy roots, while RxHub is a joint venture of the nation’s largest pharmacy benefit management companies that helps users check patient eligibility at the point of care. Prematics, on the other hand, bills itself as an ePrescribing service provider for physicians, offering servers, Internet access, printers, and handheld devices, in addition to software.

“This has to be delivered as a service, not as a software product,” Hutchinson insists. “The service actually monitors the physician’s technology infrastructure. If there’s a problem with a Wi-Fi access point, we know. If there’s a problem with a printer, we know,” he adds.

Hutchinson, who starts his new job next week, says the Prematics ScriptTone service is connected to both the RxHub and SureScripts networks. “Someone has to be that last mile to these physician practices.”

The privately held company’s business model is to partner with health plans in specific geographic locations to offer ePrescribing at no cost to doctors. Prematics’ first customer is Capital BlueCross in Central Pennsylvania, which Hutchinson says has identified as many as 2,000 physicians to participate in the initial roll-out, which began last summer.

He says Prematics will announce additional deals in the coming months.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Translational Research Briefing ON Report
Sponsored by GenoLogics

The varied collection of Bio-IT World articles and insights assembled in this Briefing ON examines:

  • The impact of integrating clinical data back into the research and development pipeline.
  • Using information gathered from physical samples, databases, and clinical trials to benefit the design and performance of future research.


Reducing bottlenecks in GMP Laboratories
Sponsored by Waters
Significant time is spent conducting quality control (QC) testing and documenting QC results during the pharmaceutical manufacturing process. GMP regulations require maintaining documentation to ensure strict compliance with established SOP’s. Completing paper documents and ensuring their authenticity creates a bottleneck in the QC laboratory. Waters® NuGenesis® SDMS Intelligent Procedure Manager, an electronic SOP workflow & documentation system, addresses the predominately manual activities required to perform an analytical method. Cycle times are reduced up to 50-75% as compared to a traditional paper trail thereby boosting productivity and accuracy.


Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Medidata Solutions

“What Will Drive Tomorrow’s Health Business Innovation: Technology, Standards or New Business Models?”

This podcast will discuss the current state of health business innovation, particularly around providing solutions for clinical trials and drug development. Executives from Medidata and SAS will address the following questions:

  • Does the health industry need more technology to drive business innovation?
  • How does the current state of industry standards impact the ability of technology to drive business innovation?
  • Is the lack of integration, inability to enter clean data or data privacy issues posing barriers to fully exploiting today’s technology?
  • Are standards and technology adoption hindered by misaligned business models?

Speakers: Glen de Vries, President of Medidata Solutions, and Jason Burke, Global Director of Health and Life Sciences Market Segments, SAS.

Download Now



More Podcasts

Job Openings


Biotechnology Information Management team
Seeks an individual to strategically lead and drive solutions for data management needs stemming from external scientific collaborations. MS in Biology, Bioinformatics, Computer Science, etc. required. Applications must be submitted at www.monsanto.com for consideration. Select req # mons-00010265. We offer very competitive salaries and an extensive benefits package. Monsanto values diversity and is an equal opportunity employer. M/F/D/V

Support Engineer
Titian leads the industry in the supply of software that empowers customers in the management of their scientific samples. Located in Hopkinton, Massachusetts, this position is responsible for the resolution of customer support issues. Candidates should hold a 4 year degree, have a technical background in software or research informatics, have 4+years of experience supporting data management and software solutions, and be proficient in C#.NET, VB6, PL/SQL, ASP. For additional information on this position and our company, visit our website at www.titian.co.uk. To apply, email resume and salary history to [email protected].

Related Resources & Products

Study Site Start-Up

eStats: PAREXEL's Bio/Pharmaceutical R&D; Statistical Sourcebook 2007/2008 Electronic Access
Key Components of a Successful Study Site Start-up: Management and Maintenance Strategy




For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to [email protected].